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Background: In the United States, more than 25 million people have diabetes. Medication adherence is known to
be important for disease control. However, factors that consistently predict medication adherence are unclear and
the literature lacks patient perspectives on how health care systems affect adherence to oral hypoglycemic agents
(OHAs). This study explored facilitators and barriers to OHA adherence by obtaining the perspectives of Veterans
Affairs (VA) patients with OHA prescriptions.
Methods: A total of 45 patients participated in 12 focus groups that explored a wide range of issues that might
affect medication adherence. Participants were patients at clinics in Seattle, Washington; San Antonio, Texas;
Portland, Oregon; Salem, Oregon, and Warrenton, Oregon.
Results: Key system-level facilitators of OHA adherence included good overall pharmacy service and several specific
mechanisms for ordering and delivering medications (automated phone refill service, Web-based prescription ordering),
as well as providing pillboxes and printed lists of current medications to patients. Barriers mirrored many of the facilitators.
Poor pharmacy service quality and difficulty coordinating multiple prescriptions emerged as key barriers.
Conclusions: VA patient focus groups provided insights on how care delivery systems can encourage diabetes
medication adherence by minimizing the barriers and enhancing the facilitators at both the patient and system levels.
Major system-level factors that facilitated adherence were overall pharmacy service quality, availability of multiple systems
for reordering medications, having a person to call when questions arose, counseling about the importance of adherence
and providing tools such as pillboxes and updated medication lists.
Keywords: Diabetes, Medication adherence, Chronic disease management, Patient self-management, Delivery of care,
Veterans, Health systems research, Pharmacy services research, Patient-oriented researchBackground
Diabetes is a serious and increasing US health concern
that affects over 25 million people [1]. Within the Veterans
Affairs (VA) health care system, diabetes is even more
common, affecting 25% of VA patients in 2010 [1]. Suc-
cessful management of this complex disease requires a
long-term and multipronged approach. As most diabetes
patients are unable to achieve sufficient glycemic control
through diet, exercise and weight loss alone, pharmacologic* Correspondence: hsu.c@ghc.org
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unless otherwise stated.therapy is a key treatment component [2]. Of US adult
patients with type 2 diabetes, 72% take at least one oral
hypoglycemic agent (OHA) [1]. However, poor adherence
to medication is a persistent problem across many diseases,
especially chronic conditions like diabetes [3]. Research also
suggests that adherence is highly variable among people
with diabetes, indicating that patients take only 7% to 64%
of their anti-diabetic drug doses [4]. Poor adherence to
OHAs is linked to intermediate and long-term health
outcomes such as higher hemoglobin A1c levels [5,6],
increased symptoms, and poorer physical and mental
functioning [7]. Nonadherence to diabetes medications is
also associated with increased health care utilization and
higher mortality [5,6].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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are well established and include age, sex, race/ethnicity,
education, and income or socioeconomic status [8-10]. In
addition, for patients managing diabetes, qualitative stud-
ies have identified a number of common patient chal-
lenges and/or needs are: 1) information needs [11-17]; 2)
personal experiences with illness, medications, and com-
plications [12,13,17-20]; 3) social support, including the
patient-physician relationship [12,15,18,19]; 4) lifestyles
and routines [19,21,22]; 5) costs [16,17,19,20]; and 6) psy-
chosocial factors [13,17,19,20]. Only a few qualitative
studies have specifically focused on diabetes medication
adherence; their findings are generally consistent with the
larger body of qualitative work on overall diabetes self-
management [21-25].
Although individual studies indicate that patient level-
factors are important to medication adherence, meta-
analyses suggest that no single, robust patient-level factor
predicts medication adherence [26]. Additionally, many
patient-level factors such as income or socioeconomic
status are largely immune to modification by health care
systems. From the perspective of health systems such as
VA, understanding organizational factors associated with
medication adherence is important to improve delivery of
care. Understanding organizational correlates of adher-
ence is also important given the American Diabetes Asso-
ciation recommendation that patients with diabetes see a
health provider every three months [27]. The literature
suggests that provider-level factors such as the patient-
physician relationship and communication, [28,29] provider
attitudes toward diabetes [30,31], and provider knowledge
and skills related to diabetes treatment [30,32] have the
potential to influence adherence behavior. However, other
potential organizational/health system correlates of adher-
ence have received far less attention.
We found no studies that specifically asked patients
what aspects of their health care system affect their adher-
ence to OHAs. While understanding patient-level factors
is critical to ensuring that system-level interventions are
designed to meet patient needs, we must also understand
patient perspectives on how health care systems either
facilitate or hinder medication adherence. Given the
frequent interaction diabetes patients have with health
care providers, facilities, and the overall delivery system,
patient perspectives are important for understanding how
systems can better support the needs of patients dealing
with chronic diseases such as diabetes. Using patient focus
groups, our study examined the experiences and perspec-
tives of VA patients who take OHAs to elicit organizational
facilitators and barriers that contribute to their medication
adherence. Since many of the study participants took medi-
cations for a variety of conditions, our findings may be
more broadly applicable to patients with multiple chronic
diseases as well as those on OHAs.Methods
Focus groups
This research was part of a larger study of VA primary care
clinics to assess variation in OHA medication adherence
and identify organizational factors associated with better
medication adherence. To obtain patients’ perspectives, we
conducted focus groups exploring issues that might affect
OHA adherence. Focus groups were chosen in order to in-
crease the diversity of opinions we were able to gather. The
focus group approach also allowed us to explore if there
were common issues raised at particular sites and by the
low adherence versus high adherence patients. The focus
group interview guide included topics such as patient views
on adherence to OHA medication regimens, challenges to
taking medications as prescribed, refill methods, VA system
barriers and facilitators, attitudes toward self-care, and open-
ness to using technology for assistance with medication
adherence (see Additional file 1 for full guide).
Study population and recruitment
Potential participants were identified from a national sam-
ple for the main study of 444,418 type 2 diabetes patients
in 559 VA primary care clinics. We identified 11 potential
clinics based on diversity of clinic-level adherence rates
and geography [33]. Five clinics in Seattle, Washington;
San Antonio, Texas; Portland, Oregon; Salem, Oregon;
and Warrenton, Oregon agreed to participate and met the
requirements for accredited human research protections
program oversight. The goal was to recruit 4 groups of
6-8 participants at each clinic. Participants were defined
as either adherent or non-adherent using a validated
medication possession ratio [34]. The ratio reflects the
proportion of days during the quarter (in this study, the
first quarter of fiscal year 2007) that the patient had all
medications in their diabetes regimen. Medication posses-
sion was ascertained using pharmacy refill records in VA ad-
ministrative databases covering all VA facilities nationwide.
Patients were defined as adherent if they had medication
available for at least 80% of the time period, a cutoff com-
monly used in studies of refill-based adherence measures
[33]. After excluding patients who died before September
2009 or no longer resided in the clinic’s state, random sam-
ples of 50 adherent and 50 nonadherent participants were
drawn from each clinic. If a clinic had fewer than 50 poten-
tial participants, all eligible patients were invited. In total,
497 potential focus group participants were identified.
Potential volunteer participants were mailed a letter with
an information statement or informed consent form (depend-
ing on the local Institutional Review Board requirements),
and a prepaid “opt-out” postcard. Patients who did not opt
out were called about participating. Of 497 potential partici-
pants who were mailed letters, 71 agreed to participate; of
these, 25 did not appear at their scheduled focus group
session (despite multiple reminder calls), and 1 withdrew
Figure 1 Process for coding transcript data.
Hsu et al. BMC Health Services Research 2014, 14:533 Page 3 of 9
http://www.biomedcentral.com/1472-6963/14/533midsession, for 45 total participants in 12 groups across 5
clinics. Groups contained only adherent or non-adherent
patients with no mixed groups. The number of partici-
pants per clinic ranged from 5 to 15. Individual group ses-
sion sizes were 1 to 9 participants. For two sessions, only
one of the scheduled participants showed up. In these
cases, a semi-structured interview using the focus group
guide was conducted and transcripts were included in the
analysis. Patients received $25 for participation.
All participants reviewed and signed a written informed
consent form before participating which discussed issues
of confidentiality; including that fact there their names
would not be associated with any quotes used. The
methods and procedures for this study were reviewed by
the Institutional Review Boards at each of the clinic sites
where focus groups were conducted:1) Veteran Affairs
Puget Sound Health Care System, Office of Research
& Development, Veteran Affairs Puget Sound Human
Research Protection Program, 2) South Texas Veterans
Health Care System Institutional Review Board, 3) Port-
land Veteran Affairs Medical Center Institutional Review
Board. All protocols were also reviewed by the institutions
where key personnel were located: 1) Group Health
Research Institute’s Institutional Review Board and 2) the
University of Washington’s Human Subjects Division.
Most of the staff working on the focus groups were profes-
sional research staff and did not occupy dual roles in
research and care delivery. The one exception was the Prin-
cipal Investigator who also provides clinical care, however
none of his patients were involved in the focus groups.Data analysis
Audio recordings were transcribed and deidentified by a
study team member (JL) who attended all focus groups.
Each participant had a unique ID number. A coding scheme
was developed based on issues that emerged while reviewing
transcript content and a priori topics of interest. Three
coders (CH, MN and JL) coded one of the transcripts using
the code list, then discussed and reconciled differences. After
revising the code list and definitions, a second transcript was
coded by all coders followed by another round of discussion
and revision. After coding the second transcript, the team
determined that agreement around the code list and defini-
tions was sufficient to code the remaining transcripts. A
single team member coded all 12 transcripts (CH), with 8
also coded by a second team member (MN or JL). The
primary and secondary coders reviewed and reconciled dif-
ferences. Figure 1 summarizes this process. Atlas.ti software
assisted with data management [35,36]. Data were sorted by
high- and low-adherence groups and reviewed by the
primary coder (CH) to ensure code accuracy and to identify
important subthemes. A coding memo summarizing find-
ings and example quotations was developed and reviewed bythe research team for face validity, appropriate breadth of
analysis, and themes for further exploration.
Patient-identified facilitators and barriers included system-
level and patient-level factors. This study defined system-
level factors as all issues linked to the organization and
distribution of health care, including provider behavior and
patient interaction with health systems. Patient-level factors
were defined as activities or issues over which the patient
had direct control or experienced daily such as lifestyle
behaviors, organizational habits, and emotional response. In
many cases, themes that patients identified as patient-level
factors were linked to system-level factors. This study
focused only on system-level factors, as patient-level factors
have been studied and our findings were consistent with
prior research [33].Results and discussion
Participant characteristics
Of the 12 focus groups at 5 sites, 7 contained high-
adherence patients. Participant ages were 50 to 89 years,
with an average of 69 years across all sites (Table 1). Partici-
pants were predominantly male with an average of 2–3
primary care visits in the index year. Nearly three-quarters
were eligible for free care in the VA system.
Participants in all groups reported comorbidities includ-
ing dementia, post-traumatic stress disorder, arthritis, car-
diac disease, hypertension, glaucoma, chronic obstructive
pulmonary disease, and cancer. Although participants were
not specifically asked about the number of medications
they were taking, 18 mentioned being on complex medica-
tion regimens in addition to OHAs, with 7 reporting 10 or
more different medications and 2 reporting more than 27
different medications. Comorbid conditions and a high
level of medication usage affected OHA adherence in
several ways including: memory loss that made it difficult
to remember to take medications, negative side effects from
drug interactions, and difficulty in managing multiple medi-
cations with different administration instructions and refill
intervals.
Table 1 Focus group participant characteristics
Characteristic All patients Patient focus group
A1† A2 A3 B4 B5 C6 C7 D8 D9 E10 E11 E12
Location 5 sites A A A B B C C D D E E E
N 45 4 3 3 1 4 9 6 4 3 5 2 1

























Female, N (%) 3 (6.7) 0 0 1 (33.3) 0 0 1 (11.1) 1 (16.7) 0 0 0 0 0
Married, N (%) 29 (64.0) 3(75) 3 (100) 3 (100) 1
(100)
3 (75) 5 (55.6) 3 (50) 2 (50) 0 (0) 5 (100) 1 (50) 0
White race, N (%) 32 (71.1) 3 (75) 0 2 (66.7) 1
(100)
2 (50) 7 (77.8) 5 (83.3) 3 (75) 2 (66.7) 5 (100) 1 (50) 1
(100)
VA primary care visits,
mean (SD) [range]
3.1 (2.3) [1-16] 3.3 (0.5) [3,4] 1.7 (0.6) [1,2] 3.7 (1.2) [3-5] 3 6.8 (6.2) [3-16] 1.7 (0.7) [1-3] 3.1 (1.7) [1-6] 2.2 (1.0) [1-3] 2.7 (0.6) [2,3] 4.0 (0.7) [3-5] 1.5 (0.7) [1,2] 5
Distance to VA in

























Free care in VA, N (%) 33 (73.3) 3 (75) 3 (100) 3 (100) 1
(100)
4 (100) 6 (66.7) 4 (66.7) 2 (50) 3 (100) 2 (40) 2 (100) 0
High school graduate,


























†The letters indicate a particular site while the numbers provider a unique identifier for each focus group.
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remember what the pills are that I’m supposed to
have, you know. So, I just have to take all my pills up
there with me, and there’s like 26 of them, and say, “I
need refills.” And then they have to go through every
single prescription to see when the refills are ready to
be done…(Group C7)
System-level facilitators of OHA adherence
Focus group participants discussed a variety of system-
level factors that they felt helped them consistently take
their diabetes medication. We grouped factors into several
general categories: 1) pharmacy-related services that facili-
tated the medication ordering; 2) provider and staff com-
munication with patients about their medications; and 3)
assisting patients in establishing routines to help them
take and refill their medications.
Pharmacy-related facilitators included good overall phar-
macy service; convenience of automated phone and Web-
based refill tools; and an option to mail medications to the
patient’s home. Positive comments about overall pharmacy
service were not common and were mentioned at only
three of the five clinics.
I’ve had nothing but good response out of [Pharmacy].
When I get low on my pills, I call and I do the
automatic order online, and I’ve never had a problem.
And even when…they can’t refill it, they get ahold of
the physician here. And obviously she signs off “yes”
and still wants to prescribe that. And I’m very grateful
for that. I don’t have to worry about it and I know it’s
going to come, as long as I order them and give them
enough time, they tell me 7-10 days and it’s here in
7-10 days. So I have no complaints. (Group C7)
Patients described a wide variety of helpful system-level
tools for ordering refills. These included phone and Web-
based prescription-ordering options; information on the
medication bottle (refill phone number, number of refills
and date); automatic refill systems that require no patient
action to trigger the refill; paper mail-in slips included
with each prescription order; and having clinic staff re-
mind them about refills during appointments.
A second category of facilitators related to the accessibility
and quality of communication with staff and providers. In
particular, patients’ ability to reach staff by phone or email
about general medication questions or needs was important
to medication regime adherence including OHAs. Patients
most often mentioned calling a clinic nurse, but occasionally,
their doctor or pharmacist filled this role. This facilitator was
spontaneously mentioned in all but 2 of the 12 groups.
I don’t have any problem ordering the medications
when I want to order them. Or I lose them, what I dois I call the nurse. They have a day nurse and a night
nurse, another day nurse and sometimes they’ll say,
“Ok, what’s the medication?” And they’ll say, “Ok, go
to the pharmacist.” And just get a small amount of it,
until you go and see your doctor, or primary care.
(Group B5)
Another related facilitator was communication with pro-
viders or other members of the patient’s care team around
the need for medications and the development of an
informed and realistic medication routine. Respondents
seemed to indicate that they took medication advice from
their care team members more seriously than comments
from pharmacists.
And when I first started, I had a schedule that I set
up that I’d mark off, so I would get in the habit. And
you have a problem when you first start out things.
So what I did was sat down with [Dr. A] and I had
him explain what you mean for each one. And he
explained when I should be taking them, and what
would be the best time. And so that I put on my
chart and that’s when I take my pills. Which I take
my pills throughout the whole day, so there’s different
times that I take pills. But sitting down and having
him explain what he wanted, because most the time
what comes on that bottle comes from the pharmacy.
That’s what they know. But, he has his own ideas,
and that was a big thing that helped in that part.
(Group E10)
The third category of facilitators helped patients estab-
lish personal systems and routines for taking and refilling
OHA and other medications. Although patients talked
about these factors on a more personal level, they covered
issues that could be addressed at a system-level. Numer-
ous patients mentioned the importance of a pillbox or a
physical organizing system such as small containers, bot-
tles or zip-top plastic bags for maintaining their medica-
tion routine. Another frequently mentioned facilitator was
a consistent daily routine; generally, a daily event was used
to trigger the taking of medications such as meals, exer-
cise, or television. Some people reinforced routines with
an alarm reminder such as the timer on their cell phone.
Finally, a few patients used a written list of medications
and when they should be taken. Based on respondent
comments, these reminder systems not only facilitated
daily medication adherence, but also helped patients
remember refills. Several respondents noted that setting
up the pillbox at the beginning of the week triggered them
to order meds before they ran out.
I fill my canister on Sunday evenings. So at that time
I’m looking at each vial of medication to determine
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left in a container, I’ll call it in. (Group B5)
High adherers mentioned combining daily routines with
pill organization more often than low-adherent respondents.
Also, respondents in the high-adherence groups mentioned
having pillboxes and daily routines twice as often as the low-
adherence groups and gave more detailed descriptions of
systems and routines. Clinics that provided pillboxes, up-
dated medication lists at routine appointments, and counsel-
ing on the importance of OHA medication adherence and
routines appeared to support routine patient-level behaviors
that ensured adherence.System-level barriers to OHA Adherence
Respondents reported a number of system-level barriers to
OHA medication adherence. These barriers were primarily
in three categories: 1) concerns about the quality of phar-
macy services; 2) communication issues including commu-
nication breakdowns between care teams and pharmacy;
and 3) lack of education and support around specific medi-
cation regimes.
The most frequent category of medication adherence
barriers was pharmacy-related factors, focusing on poor
overall pharmacy service. Items reflecting poor pharmacy
service included insufficient staffing, poor quality control,
and lack of a customer-service orientation. More spe-
cific pharmacy-related barriers were also mentioned
and included excessive wait times, both in the clinic
and on the phone; inability to reach someone to resolve
prescription problems; problems with ordering and/or
delivery services; and dissatisfaction with formulary.
If I had an appointment and I came out here let’s say,
11 o’clock in the morning - had an appointment, had
to go down and get some medicine because it was a
fresh prescription, new prescription. And I’ve been out
here for 5 hours. (Group D9)
But here a couple months ago, the (pharmacy) down
here - messed up somehow. I don’t know who did it or
how they did it or whatever, but I kept calling them
and calling them for 6 weeks, 7 weeks. … I couldn’t get
ahold of a person. (Group E11)
Another category of barriers related to communication
and the ability of different departments to coordinate
medication logistics. Respondents reported communication
breakdowns between departments, the most commonly
mentioned were between providers and pharmacy. Providers
were generally perceived as advocating for patients, but their
communications did not always achieve the desired results
at the pharmacy.I think it’s a doctor-pharmacy problem, because I see
my physician every year, once a year, and sometimes
more frequently than that, and there’re still mix ups
and cancellations. You know, I talked to my doctors
about that, now with 2 of them, and from both of
them at completely different offices are saying, they
fight with VA pharmacy all the time to no avail. And
now they’re even saying, “If it has to do with prescrip-
tions, go talk to the pharmacy because I don’t get any
different treatment than you do.” (Group C6)
Another related but separate issue was the lack of align-
ment in prescription refill timing. Patients with several types
of medications had to order different medications at differ-
ent times, requiring frequent refill orders. Several patients
reported that providers cancelled and reordered medications
to increase alignment, however even this action did not
always resolve the problem.
I’m taking enough medications though, that almost all
of them come in varying units. The metformin comes in
180 pills and luckily the glyburide come in 180 pills. But
some of the other pills I take are 30-day supply, 60-day
supply, and so even though they’re maintenance and I’ve
been taking them forever… it would be really nice if all my
pills came with the same supply… and I have forgotten to
order them, I thought I had more of that, or I thought I
had more of this. (Group A3)
The final communication-related barrier to OHA adher-
ence was lack of education about medications and/or diffi-
culties managing a complex medication regimen. Five of
the 12 groups mentioned a lack of understanding about
when to take medications and what types of modifications
could be safely made to medication routines. Patients
wanted to streamline their medication regimen as much as
possible while maintaining safety and effectiveness. Some
respondents rejected complicated instructions in favor of
a medication schedule they could achieve.
I take pills that I take before I go to bed because I got
one pill that’s supposed to help me sleep. It doesn’t too
much. So I take me Metformin every day in the
evening at bed time. And then when I get up I take my
medicine, about 12 hour difference in between. And I
also got another drop I got to take at bedtime. I do all
my medicating then. I don’t know if that’s good or bad.
(Group E10)
Related to concerns about education on “doable” medica-
tion regimes, participants talked about lifestyle factors that
affected adherence. In some cases, the amount of system-
level assistance and coaching patients had received to help
them modify or accommodate personal barriers was unclear.
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as a barrier. However, respondents did not directly associ-
ate cost with not getting medications and medication
adherence. A few respondents stated that copayments were
difficult to manage on a fixed income; however none stated
that they did not reorder medications because of lack of
funds or cost.
Discussion
The findings from our focus groups with VA patients who
took OHAs provide patient perspectives on how health care
delivery systems facilitate or create barriers to obtaining and
taking medications to control diabetes. System-level facilita-
tors included good overall pharmacy service and several
specific mechanisms for ordering and delivering medications
(automated phone refill service, Web-based prescription
ordering). Several important facilitators were linked to com-
munication between the patient and the system including
the ability to contact someone with questions and consult
with providers regarding rationales for medication choices
and problem-solving around daily medication regimes.
Barriers mirrored many of the facilitators with the im-
portance of pharmacy service quality emerging as central.
Another important barrier was a lack of alignment among
prescriptions, which made it difficult for patients on mul-
tiple medications to track and order refills. Insufficient
communication and education also emerged as a barrier.
This is one of the first studies to look specifically at
system-level facilitators and barriers of OHA adherence
from patients’ perspectives. However, many of the themes
that emerged were consistent with patient-level correlates
of adherence mentioned in the literature such as support-
ing patients in developing a medication routine and pro-
viding clear and consistent communication and education
about the reasons for particular medications and sched-
ules. New insights that emerged from this study include
the importance of efficient and effective pharmacy systems
and the need to align medication schedules to facilitate
daily administration and refills. An efficient and effective
pharmacy clearly emerged as a central system-level facili-
tator, with numerous specific factors critical to patient
adherence including order and delivery services, wait
times, quality control, and being able to reach someone
with questions or concerns. Our findings on the efficiency
of the VA pharmacy as a facilitator of adherence are consist-
ent with a prior study showing that patients in clinics where
the pharmacy is not perceived as a bottleneck in the flow of
care exhibit the highest rates of OHA adherence [37].
Innovations in health care information technology and
customized medication blister packs could address the
challenges identified in this study. Currently, VA is adopting
a new model of health delivery by providing care through
Patient Care Aligned Teams (PACT), based upon the
Patient-centered Medical Home model [38]. Pharmacistsare increasingly being integrated into primary care teams
that are the central component of PACT. Having a member
of the patient’s care team assess the patient’s understanding
and beliefs about their diabetes medication, and helping
them find tools to integrate OHAs into their lifestyle and
self-care routines could address the gaps in care discussed
by the focus groups in our study.Limitations
While generating important insights, this study also has
limitations. First, the VA is a large, integrated health care
system with unique advantages and challenges to provid-
ing health care. Therefore, not all insights will translate
to other settings. Also, the study respondents repre-
sented a specific demographic group—older men. How-
ever, our findings were consistent with the general
literature on diabetes management and medication ad-
herence. OHA adherence was measured for the first
quarter of fiscal year 2007 and correlated strongly with
annual OHA adherence. Measuring adherence closer to
the focus group sessions was not practical because of data
lags and human-subject review delays. Since site recruitment
was lower than anticipated, we did not explore how site-
specific systems influence adherence. We also had challenges
recruiting individuals for the low-adherence groups, so their
perspectives might not be represented as well as high-
adherence patients.Conclusions
Adherence to an OHA medication regimen is critical to
many people with diabetes. With diabetes predicted to affect
52% of Americans by 2020, guiding patients in effectively
managing this chronic condition is increasingly important
for preventive care [39]. OHAs and similar medications can
minimize complications and prevent or delay disease pro-
gression. However, research shows that many patients have
difficulty adhering to OHA medication regimens [5,8]. This
study draws insights from focus groups with VA patients to
understand how care delivery systems can design system-
level and patient-level processes and services to minimize
barriers and enhance facilitators to OHA adherence. Factors
that encouraged medication adherence tended to simplify,
routinize, and standardize the processes of taking and refill-
ing medicines in general. Other factors ensured that trusted
members of the patient’s care team answered medication-
related questions. We hope that this research will help spur
system-level innovation and experimentation that improves
medication adherence and increases the quality and effi-
ciency of care for diabetic patients. Furthermore, many of
the insights discussed here could apply to other chronic
conditions that require adherence to a complex daily medi-
cation regimen.
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